| ESEIX | GFACX | ESEIX / GFACX | |
| Total Expense Ratio | 0.80 | 1.35 | 59% |
| Annual Report Gross Expense Ratio | 0.81 | 1.35 | 60% |
| Fund Existence | 15 years | 25 years | - |
| Gain YTD | -4.494 | 5.156 | -87% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 234M | 357B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -19.00 | -0.98 | 1,940% |
| Returns for 3 years | -10.60 | 27.74 | -38% |
| Returns for 5 years | -20.07 | 3.92 | -512% |
| Returns for 10 years | 58.09 | 76.09 | 76% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VGMS | 50.85 | 0.01 | +0.01% |
| Vanguard Multi-Sector Income Bond ETF | |||
| EVUS | 36.01 | N/A | N/A |
| iShares ESG Aware MSCI USA Value ETF | |||
| MYCO | 24.00 | -0.05 | -0.19% |
| State Street® My2035 Corporate Bond ETF | |||
| GURU | 67.35 | -0.55 | -0.81% |
| Global X Guru™ ETF | |||
| FBT | 245.06 | -7.60 | -3.01% |
| First Trust NYSE Arca Biotech ETF | |||